This is a highly speculative equity masquerading as a growth tech play. With no P/E or Forward P/E, negative EPS of -5, and expected EPS of -$0.82 next year, profitability is not just absent—it’s deeply impaired. A Price/Sales of 9.3 combined with an Operating Margin of -48.00% and ROIC of -66.60% signals investors are paying a premium multiple for a company that destroys capital. The Altman Z-Score of 2 places it in the gray zone, not distressed but certainly not safe, and the Piotroski F-Score of 4 confirms mediocre financial strength. This is not a mispricing opportunity—it is a balance sheet and earnings execution story that must materially improve before valuation can be justified.